22 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents for COVID ... Medications #Treatment #COVID19 ... #Pharmacology # ... Table #Management
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
causing COVID-19 ... here is a quick overview ... ivermectin… #COVID19 ... EmergencyMedicine #Pharmacology ... #Antiviral #Management
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
chronic hepatitis C virus ... (HCV) infection ... DAAs #Antivirals #table ... HepC #HepatitisC #Management ... #Pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... correlate with severe COVID ... Siltuximab 11mg/kg IV ... #Pharmacology # ... Management #Medications
Oral anti-hypertensives with relative fast onset of action (Hypertensive Emergency)

The key concern with oral antihypertensive agents
you escalate the dose ... weaning of the IV ... Hypertensive #Emergency #Management ... #Pharmacology # ... Table #BloodPressure
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... be considered (doses ... PO in 2 divided doses ... #Treatment #management ... infections #HIVAIDS #pharmacology
HIV PrEP (Pre-Exposure Prophylaxis) - Truvada 

HIV Pre-Exposure Prophylaxis (PrEP) is available in the form of
single once-daily tablet ... & side effect management ... from TDF (TAF does ... effective measure of prevention ... Truvada #Monitoring #Management
HIV Antiretroviral Regimen Components 
Dual NRTI Backbone + Third Agent 

The general HIV antiretroviral medication regimen
now 10 single-tablet ... product is just 1 tablet ... and not missing doses ... #Pharmacology # ... Management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Achieve a total dose ... achieve total dose ... Leishmaniasis #Prevention ... #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... chew, or crush tablet ... mucosal #IDSA #Prevention ... #Treatment #management ... infections #HIVAIDS #pharmacology